Implanet S.A. (ALIMP.PA)

EUR 0.1

(-6.64%)

Long Term Debt Summary of Implanet S.A.

  • Implanet S.A.'s latest annual long term debt in 2023 was 1.38 Million EUR , down -44.36% from previous year.
  • Implanet S.A.'s latest quarterly long term debt in 2024 Q2 was 1.57 Million EUR , down 0.0% from previous quarter.
  • Implanet S.A. reported annual long term debt of 2.48 Million EUR in 2022, down -50.79% from previous year.
  • Implanet S.A. reported annual long term debt of 5.04 Million EUR in 2021, up 94.38% from previous year.
  • Implanet S.A. reported quarterly long term debt of 1.91 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Implanet S.A. reported quarterly long term debt of 1.38 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Implanet S.A. (2023 - 2012)

Historical Annual Long Term Debt of Implanet S.A. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 1.38 Million EUR -44.36%
2022 2.48 Million EUR -50.79%
2021 5.04 Million EUR 94.38%
2020 2.59 Million EUR 94.1%
2019 1.33 Million EUR 29.03%
2018 1.03 Million EUR 11.15%
2017 933 Thousand EUR 19.62%
2016 780 Thousand EUR -45.19%
2015 1.42 Million EUR 13.67%
2014 1.25 Million EUR -61.04%
2013 3.21 Million EUR 255.74%
2012 903.32 Thousand EUR 0.0%

Peer Long Term Debt Comparison of Implanet S.A.

Name Long Term Debt Long Term Debt Difference
Affluent Medical SA 14.41 Million EUR 90.41%
Bluelinea Société Anonyme 2.11 Million EUR 34.523%
Carmat SA 57.64 Million EUR 97.603%
Diagnostic Medical Systems S.A. 13.19 Million EUR 89.529%
Euromedis Groupe 5.08 Million EUR 72.828%
Eurobio Scientific Société anonyme 81.23 Million EUR 98.299%
Ikonisys S.A. 3.2 Million EUR 56.913%
Median Technologies SA 21.64 Million EUR 93.614%
SpineGuard SA 1.87 Million EUR 26.319%
Theraclion SA 1.95 Million EUR 29.155%
Euroapi S.A. 15.5 Million EUR 91.084%
Guerbet SA 360.51 Million EUR 99.617%